Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value: $354M (100.0% shares, 0.0% debt)

Holdings (26)

LOXO ONCOLOGY INC 9.4%
Value $33.16M Shares 360,000 Est. Cost $28.44 Unrealized
MYOKARDIA INC 6.8%
Value $24M Shares 560,000 Est. Cost $22.11 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 6.6%
Value $23.5M Shares 200,000 Est. Cost $73.35 Unrealized +16.4%
SGMO SANGAMO THERAPEUTICS INC 5.9%
Value $21M Shares 1,400,000 Est. Cost $4.96 Unrealized +123.1%
BLUEPRINT MEDICINES CORP 5.9%
Value $20.76M Shares 298,000 Est. Cost $31.57 Unrealized
BLUEBIRD BIO INC 5.6%
Value $19.92M Shares 145,000 Est. Cost $115.06 Unrealized
FOUNDATION MEDICINE INC 5.4%
Value $19.3M Shares 480,000 Est. Cost $18.96 Unrealized
KITE PHARMA INC 5.4%
Value $19.06M Shares 106,000 Est. Cost $94.67 Unrealized
SPARK THERAPEUTICS INC 5.3%
Value $18.68M Shares 209,474 Est. Cost $55.96 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 4.8%
Value $17.02M Shares 255,000 Est. Cost $51.71 Unrealized +16.2%
VYGR VOYAGER THERAPEUTICS INC 4.7%
Value $16.78M Shares 815,000 Est. Cost $14.18 Unrealized
SAGE THERAPEUTICS INC 4.2%
Value $14.95M Shares 240,000 Est. Cost $47.85 Unrealized
GENMARK DIAGNOSTICS INC 4.1%
Value $14.45M Shares 1,500,000 Est. Cost $10.08 Unrealized
EVH EVOLENT HEALTH INC 4.0%
Value $14.15M Shares 795,000 Est. Cost $18.96 Unrealized +8.7%
GLOBAL BLOOD THERAPEUTICS IN 3.3%
Value $11.8M Shares 380,000 Est. Cost $26.45 Unrealized
AUDENTES THERAPEUTICS INC 3.2%
Value $11.2M Shares 400,000 Est. Cost $17.77 Unrealized
CLOVIS ONCOLOGY INC 3.0%
Value $10.51M Shares 127,500 Est. Cost $88.33 Unrealized
CDXS CODEXIS INC 2.8%
Value $9.809M Shares 1,475,000 Est. Cost $4.76 Unrealized +16.3%
ILMN ILLUMINA INC 2.5%
Value $8.765M Shares 44,000 Est. Cost $176.76 Unrealized +5.3%
JOUNCE THERAPEUTICS INC 1.8%
Value $6.229M Shares 399,825 Est. Cost $17.55 Unrealized
TESARO INC 1.4%
Value $4.97M Shares 38,500 Est. Cost $144.97 Unrealized
SYROS PHARMACEUTICALS INC 1.1%
Value $3.771M Shares 256,215 Est. Cost $14.07 Unrealized
CTMX CYTOMX THERAPEUTICS INC 0.9%
Value $3.225M Shares 177,500 Est. Cost $15.07 Unrealized +3.5%
EDIT EDITAS MEDICINE INC 0.9%
Value $3.201M Shares 133,333 Est. Cost $20.61 Unrealized -7.6%
FATE FATE THERAPEUTICS INC 0.6%
Value $2.178M Shares 550,000 Est. Cost $3.83 Unrealized -11.2%
OVID OVID THERAPEUTICS INC 0.5%
Value $1.778M Shares 207,500 Est. Cost $13.06 Unrealized -36.2%